ONCY:NASDAQ
Oncolytics Biotech Inc
$0.37
arrow_downward
-0.54%(-0.0020) 1D
$0.36
arrow_downward
-1.73% (-0.0064)bedtimeAfter hours
Closed: Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONCY...
Open
$0.38
High
$0.39
Low
$0.34
Mkt. cap
48.78M
Avg. vol.
1.27M
Volume
1.26M
52-wk high
$1.30
52-wk low
$0.34
Beta
1.26
Shares outstanding
127.51M
No. of employees
29
Open
$0.38
High
$0.39
Low
$0.34
Mkt. cap
48.78M
Avg. vol.
1.27M
Volume
1.26M
52-wk high
$1.30
52-wk low
$0.34
Beta
1.26
Shares outstanding
127.51M
No. of employees
29
News stories
From web sources and news partners
kalkine.ca
·
15 hours ago
Which Factors Will Drive Oncolytics Biotech Inc. (NASDAQ:ONCY) at Its November 16, 2026 Q3 Report?
Investing.com
·
2 days ago
Oncolytics enters supply deal with Coherus for cancer study
Profile
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc
CEO-
Employees29
Founded1998
HeadquartersCalgary, Alberta, Canada
SectorHealth Care
IndustryBiotechnology
Websiteoncolyticsbiotech.com